News | October 12, 2022
Merck recognized on Fortune’s 2022 change the World List
This recognition marks the third time in five years that Merck has been included on Fortune’s Change the World list.
This recognition marks the third time in five years that Merck has been included on Fortune’s Change the World list.
Through this agreement, Lupin will introduce two new formulations, a fixed-dose combination of Rifapentine + Isoniazid and Rifapentine 300 mg standalone tablets, at an affordable price
Acquisition brings leading sickle cell disease portfolio and pipeline to Pfizer with potential to address critical needs in an underserved patient community
Glenmark is the first company in India to launch Thiazolidinedione Lobeglitazone (0.5 mg).
Daffodils by Artemis is a premiere luxury birthing centre offering mother and child care services.
The card-to-cloud device was launched into the U.S. and many other markets and is designed to work without an embedded communications module.
All claims made by Seagen regarding Daiichi Sankyo antibody drug conjugates are denied
The two generic drugs have been launched under the brand names Jankey & Sitenali.
Advancing to IND-enabling studies with multiple drug candidates
This acquisition is in line with Cipla's strategic imperative to augment the company's wellness portfolio for bringing about a shift from an illness to a wellness mindset.
Subscribe To Our Newsletter & Stay Updated
